Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S, F.C.P.S
Internal Medicine Specialist
MBBS, MCPS, MRCGP
Endocrinologist
M.B.B.S., M.R.C.P (Gen. Medicine), Specialty Certificate in Endocrine and Diabetes
Endocrinologist
M.B.B.S., M.R.C.P (Gen. Medicine), Specialty Certificate in Endocrine and Diabetes
Cardiologist
M.B.B.S, Dip. In (Diabetes) , F.C.P.S.
Gastroenterologist
M.B.B.S, F.C.P.S. (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures